BASILEA LABS

Serial Number 88056364
606

Registration Progress

Application Filed
Jul 27, 2018
Under Examination
Sep 3, 2019
Approved for Publication
Jul 9, 2019
Published for Opposition
Jul 9, 2019
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: BASILEA LABS
Previous Owner: Basilea Pharmaceutica AG
Classes: 001, 005

Trademark Image

BASILEA LABS

Basic Information

Serial Number
88056364
Filing Date
July 27, 2018
Published for Opposition
July 9, 2019
Abandonment Date
October 10, 2022
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 10, 2022
Classes
001 005

Rights Holder

Basilea Pharmaceutica AG

03
Address
Grenzacherstrasse 487
Basel 4058
CH

Ownership History

Basilea Pharmaceutica AG

Original Applicant
03
4058 Basel CH

Basilea Pharmaceutica AG

Owner at Publication
03
Basel CH

Legal Representation

Attorney
Evan A. Raynes

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

38 events
Date Code Type Description Documents
Oct 11, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Oct 10, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 26, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 25, 2022 EX5G S SOU EXTENSION 5 GRANTED Loading...
Feb 20, 2022 EXT5 S SOU EXTENSION 5 FILED Loading...
Feb 25, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Feb 20, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 3, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 31, 2021 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jul 31, 2021 EXT4 S SOU EXTENSION 4 FILED Loading...
Jul 31, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 16, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 12, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 12, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Feb 12, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 13, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 11, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 11, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 11, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 15, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 13, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 13, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 13, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 3, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 9, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 9, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 19, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 31, 2019 ALIE A ASSIGNED TO LIE Loading...
May 17, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 15, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 14, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 14, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 21, 2018 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED Loading...
Nov 21, 2018 GPRA F PRIORITY ACTION E-MAILED Loading...
Nov 21, 2018 CPRA R PRIORITY ACTION WRITTEN Loading...
Nov 14, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 3, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 31, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Diagnostic preparations for clinical or medical laboratory use; Diagnostic reagents for clinical or medical laboratory use
First Use Anywhere: 0
First Use in Commerce: 0
Class 005
Pharmaceutical and veterinary preparations for the treatment or prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; Pharmaceutical and veterinary preparations for the treatment of infections caused by bacteria, fungi, viruses and rheumatoid arthritis; Pharmaceutical and veterinary preparations for the treatment of diseases, disorders and conditions in the area of oncology
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
001 005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"LABS"